Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Leukaemia hijacks a neural mechanism to invade the central nervous system.

Yao H, Price TT, Cantelli G, Ngo B, Warner MJ, Olivere L, Ridge SM, Jablonski EM, Therrien J, Tannheimer S, McCall CM, Chenn A, Sipkins DA.

Nature. 2018 Aug;560(7716):55-60. doi: 10.1038/s41586-018-0342-5. Epub 2018 Jul 18.

PMID:
30022166
2.

E-Selectin and SDF-1 regulate metastatic trafficking of breast cancer cells within the bone.

Price TT, Sipkins DA.

Mol Cell Oncol. 2016 Jul 26;4(4):e1214771. doi: 10.1080/23723556.2016.1214771. eCollection 2017.

3.

Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone.

Price TT, Burness ML, Sivan A, Warner MJ, Cheng R, Lee CH, Olivere L, Comatas K, Magnani J, Kim Lyerly H, Cheng Q, McCall CM, Sipkins DA.

Sci Transl Med. 2016 May 25;8(340):340ra73. doi: 10.1126/scitranslmed.aad4059.

PMID:
27225183
4.

Rewiring the niche: sympathetic neuropathy drives malignant niche transformation.

Price T, Sipkins DA.

Cell Stem Cell. 2014 Sep 4;15(3):261-262. doi: 10.1016/j.stem.2014.08.012.

5.

Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.

Boyerinas B, Zafrir M, Yesilkanal AE, Price TT, Hyjek EM, Sipkins DA.

Blood. 2013 Jun 13;121(24):4821-31. doi: 10.1182/blood-2012-12-475483. Epub 2013 Apr 15.

6.

Stem cell factor expression in B cell malignancies is influenced by the niche.

Fox MF, Pontier A, Gurbuxani S, Sipkins DA.

Leuk Lymphoma. 2013 Oct;54(10):2274-80. doi: 10.3109/10428194.2013.777067. Epub 2013 Apr 2.

PMID:
23418895
7.

HSPCs in the balance: The vascular niche.

Boyerinas B, Sipkins DA.

Cell Stem Cell. 2010 Dec 3;7(6):645-6. doi: 10.1016/j.stem.2010.11.021. No abstract available.

8.

The stem cell niche in health and malignancy.

Burness ML, Sipkins DA.

Semin Cancer Biol. 2010 Apr;20(2):107-15. doi: 10.1016/j.semcancer.2010.05.006. Epub 2010 May 25. Review.

PMID:
20510363
9.

Rendering the leukemia cell susceptible to attack.

Sipkins DA.

N Engl J Med. 2009 Sep 24;361(13):1307-9. doi: 10.1056/NEJMcibr0904291. No abstract available.

PMID:
19776414
10.

Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells.

Colmone A, Amorim M, Pontier AL, Wang S, Jablonski E, Sipkins DA.

Science. 2008 Dec 19;322(5909):1861-5. doi: 10.1126/science.1164390.

11.

Chemotherapy and the bone marrow stroma.

Sipkins DA.

Leuk Lymphoma. 2008 Jan;49(1):17-8. doi: 10.1080/10428190701784748. No abstract available.

PMID:
18203006
12.

Beyond angiogenesis: the role of endothelium in the bone marrow vascular niche.

Colmone A, Sipkins DA.

Transl Res. 2008 Jan;151(1):1-9. Epub 2007 Oct 4. Review.

PMID:
18061122
13.

Real-time detection of circulating apoptotic cells by in vivo flow cytometry.

Wei X, Sipkins DA, Pitsillides CM, Novak J, Georgakoudi I, Lin CP.

Mol Imaging. 2005 Oct-Dec;4(4):415-6. No abstract available.

14.

In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment.

Sipkins DA, Wei X, Wu JW, Runnels JM, Côté D, Means TK, Luster AD, Scadden DT, Lin CP.

Nature. 2005 Jun 16;435(7044):969-73.

15.

ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging.

Sipkins DA, Gijbels K, Tropper FD, Bednarski M, Li KC, Steinman L.

J Neuroimmunol. 2000 Apr 3;104(1):1-9.

PMID:
10683508
16.

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging.

Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KC.

Nat Med. 1998 May;4(5):623-6.

PMID:
9585240
17.

Paramagnetic polymerized liposomes as new recirculating MR contrast agents.

Storrs RW, Tropper FD, Li HY, Song CK, Sipkins DA, Kuniyoshi JK, Bednarski MD, Strauss HW, Li KC.

J Magn Reson Imaging. 1995 Nov-Dec;5(6):719-24.

PMID:
8748492

Supplemental Content

Loading ...
Support Center